Tampa, FLNCT06619990Now EnrollingIRB Ready

Ulcerative Colitis (UC) Clinical Trial in Tampa, FL

Access cutting-edge ulcerative colitis (uc) treatment through this clinical trial at a research site in Tampa. Study-provided care at no cost to qualified participants.

Sponsored by Xencor, Inc.

Quick Self-Assessment

See if you qualify for this Tampa location

Preparing your pre-screening questions…

Expert Care in Tampa

Access ulcerative colitis (uc) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ulcerative colitis (uc) treatment provided free

Apply for This Tampa Location

Check if you qualify for this ulcerative colitis (uc) clinical trial in Tampa, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tampa

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tampa site if eligible
  4. 4Begin participation

About This Ulcerative Colitis (UC) Study in Tampa

Brief summary The Phase 1 study described herein will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XmAb942 in healthy volunteers (Parts A and B). Part C of this study will be a Phase 2 study to evaluate XmAb942 in participants with ulcerative colitis (UC).

Sponsor: Xencor, Inc.

Who Can Participate

Inclusion Criteria

Parts A and B
Must be in good health with no significant medical history
Clinical laboratory values within normal range
BMI 18-35 (inclusive)
Contraceptive use by men or women consistent with local regulations
Able and willing to provide written informed consent Part C
Must be in good health with no significant medical history
UC diagnosis ≥ 3 months prior to screening
Diagnosis of moderately to severely active UC as defined by a (MMS) ≥ 5, with a MES ≥ 2 and RBS ≥ 1
Evidence of UC extending ≥ 15 cm from the anal verge, as determined by screening colonoscopy
Must have inadequate response to, loss of response to, or intolerance to at least 1 of the conventional or advanced therapies of UC
Able and willing to provide written informed consent

Exclusion Criteria

Parts A and B
Any physical or psychological condition that prohibits study completion
History of suicidal behavior or suicidal ideation
Heavy use of nicotine containing products
HIV, hepatitis B and hepatitis C positive
Cardiac arrhythmia, or clinically significant abnormal ECG
Active use of prescription medications within 14 days of Day -1
Active use of over-the-counter, or herbal medication within 7 days of Screening
Other investigational products within 30 days
Blood or plasma donation within 60 days
Pregnant or breastfeeding Part C
Any physical or psychological condition that prohibits study participation
Diagnosis of Crohn disease, indeterminate colitis, indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, radiation colitis, and diverticular disease associated with colitis.
Positive screen for Clostridium difficile (C. Difficile) toxins
HIV, hepatitis B and hepatitis C positive
Cardiac arrhythmia, or clinically significant abnormal ECG
Pregnant or breastfeeding Other protocol defined inclusion/exclusion criteria apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tampa?

Yes, this clinical trial (NCT06619990) has an active research site in Tampa, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Ulcerative Colitis (UC) Treatment Options in Tampa, FL

If you're searching for ulcerative colitis (uc) treatment options in Tampa, FL, this clinical trial (NCT06619990) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tampa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ulcerative colitis (uc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ulcerative colitis (uc) clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Tampa, FL

See all rheumatoid arthritis clinical trials recruiting in Tampa — not just this study.

Browse Rheumatoid Arthritis Trials in Tampa →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsUlcerative Colitis TrialsInflammatory Bowel Disease TrialsAll Conditions →

Ready to Join in Tampa?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tampa, FL